Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes

Antiviral Research

Volumn 34, Issue 1, 1997, Pages 27-37

  Barnard, D L ^a   Hill, C L ^b   Gage, T ^a   Matheson, J E ^a   Huffman, J H ^a   Sidwell, R W ^a   Otto, M I ^c   Schinazi, R F ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c Avid Therapeutics Inc   (United States)

Author keywords

Antiviral; Cytopathic inhibition assay; Neutral red uptake assay; Polyoxometalate; Respiratory syncytial virus

Indexed keywords

ANTIVIRUS AGENT; GERMANIUM DERIVATIVE; METAL DERIVATIVE; NIOBIUM; PLATINUM DERIVATIVE; SILICON DERIVATIVE; TUNGSTEN DERIVATIVE; ZIRCONIUM DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DOSE RESPONSE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STRUCTURE ACTIVITY RELATION; VIRUS ADSORPTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS;

EID: 0030939013     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(96)01019-4     Document Type: Article

References (32)

1. Cavenaugh, P.R., Jr., Moskwa, P.S., Donish, W.H., Pera, P.J., Richardson, D. and Andrese, A.P. (1990) A semi-automated neutral red based chemosensitivity assay for drug screening. Invest. New Drugs 8, 347-354.
2. Collins, P.L., McIntosh, K. and Chanock, R.M. (1996) Respiratory syncytial virus. In: B.N. Fields, D.M. Knipe and P.M. Howley (Eds), Fields Virology, pp. 1313-1351. Lippencott-Raven Publishers, Philadelphia, PA.
3. 2O: synthesis, structure, and properties. Inorgan. Chem. 24, 4610-4614.
4. Dabbabi, M. and Boyer, M. (1976) Syntheses et proprietes d'hexaniobo(V)-tungstates(VI). J. Inorgan. Nuclear Chem. 38, 1011-1014.
5. 17O Nuclear magnetic resonance spectroscopy of polyoxometalates. 1. Sensitivity and resolution. Inorgan. Chem. 18, 93-103.
6. 5-. J. Am. Chem. Soc. 106, 7274-7277.
7. + salt. Inorgan. Chem. 28, 1573-1579.
8. H2O. An inorganic cryptate. J. Am. Chem. Soc. 98, 3850-3052.
9. Fukuma, M., Seto, Y. and Yamase, T. (1991) In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus. Antiviral Res. 16, 327-339.
10. H2O. Inorgan. Chem. 32, 3378-3381.
11. 2O (M = Mn(II), n = 53, M = Ni(II), n = 52) - An antiferromagnetic Mn(II) tetramer and a ferromagnetic Ni tetramer. Inorgan. Chem. 33, 4016-4022.
12. Hill, C. L., Hartnup, M., Faraj, M. et al. (1990a) Polyoxometalates as inorganic anti-HIV-1 compounds. Structure-activity relationships. In: R. Diasio and J.-P. Sommadossi (Eds), Advances in Chemotherapy of AIDS, Pharmacology and Therapeutics, pp. 33-41. Pergamon, New York.
13. Hill, C.L., Weeks, M.S. and Schinazi, R.F. (1990b) Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates. J. Med. Chem. 33, 2767-2772.
14. Hosoya, M., Balzarini, J., Shigeta, S. and De Clercq, E. (1991) Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins. Antimicrob. Agents Chemother. 35, 2515-2520.
15. Ikeda, S., Neyts, J., Yamamoto, N. et al. (1993) In vitro activity of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses. Antiviral Chem. Chemother. 4, 253-262.
16. Inouye, Y., Toutake, Y., Yoshida, T., Yamamoto, A. and Nakamura, S. (1991) Antiviral activity of polyoxomolybdoeuropate (PM-104) against human immunodeficiency virus type 1. Chem. Pharm. Bull. (Tokyo) 39, 1638-1640.
17. Inouye, Y., Toutake, Y., Kunihara, J. et al. (1992) Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase. Chem. Pharm. Bull. (Tokyo) 40, 850-857.
18. Jasmin, C., Raybaud, N., Chermann, J.-C. et al. (1973) In vitro effects of silicotungstate on some RNA viruses. Biomedicine 18, 319-327.
19. Jasmin, C., Chermann, J.-C., Herve, G. et al. (1974) In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. J. Natl. Cancer Inst. 53, 469-479.
20. Johnson, P.R., Spriggs, M.K., Olmsted, R.A. and Collins, P.L. (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA 84, 5625-5629.
21. 38. Preparation, properties, and structure determination by tungsten-183 NMR. Inorgan. Chem. 22, 818-822.
22. Lerch, R.A., Anderson, K. and Wertz, G.W. (1990) Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment of protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. J. Virol. 64, 5559-5569.
23. Levine, S., Klaiber-Franco, R. and Paradiso, P.R. (1987) Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus., J. Gen. Virol. 68, 2521-2524.
24. Papaconstantinou, E., Dimotikali, D. and Politou, A. (1980) Photochemistry of heteropoly electrolytes. The 18-molybdodiphosphate. Inorg. Chim. Acta 46, 155.
25. Reed, L.J. and Muench, H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
26. Shigeta, S., Mori S., Watanabe, J. et al. (1995a) In vitro antimyxovirus and anti-human immunodeficiency virus activities of polyoxometalates. Antiviral Chem. Chemother. 6, 114-122.
27. Shigeta, S., Mori S., Watanabe, J., Yamasi, T., Hill, C.L. and Schinazi, R.F. (1995b) Anti-influenza activities of polyoxometalates. Antiviral Res. 26, A298.
28. Sidwell, R.W. and Huffman, J.H. (1971) Use of disposable micro-tissue culture plates for antiviral and interferon induction studies. Appl. Microbiol. 22, 7979-7801.
29. Sokal, R.R. and Rohlf, F. J. (1981) Biometry. W.H. Freeman, San Francisco, pp. 565-572.
30. Take, Y., Tokutake, Y., Inoue, Y. et al. (1991) Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolytungstates in vitro. Antiviral Res. 15, 113-124.
31. Weeks, M. S., Hill, C. L. and Schinazi, R. F. (1992) Synthesis, characterization and anti-human immunodeficiency virus activity of water soluble salts of polyoxotungstate anions with covalently attached organic groups. J Med. Chem. 35, 1216.
32. Yamamoto, A., Schols, N. D., De Clercq, E. et al. (1992) Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Mol. Pharmacol. 42, 1109-1117.